当前位置: 首页 >> 检索结果
共有 1695 条符合本次的查询结果, 用时 5.5953445 秒

421. ICU care associated with symptoms of depression and posttraumatic stress disorder among family members of patients who die in the ICU.

作者: Erin K Kross.;Ruth A Engelberg.;Cynthia J Gries.;Elizabeth L Nielsen.;Douglas Zatzick.;J Randall Curtis.
来源: Chest. 2011年139卷4期795-801页
Psychologic symptoms of posttraumatic stress disorder (PTSD) and depression are relatively common among family members of patients who die in the ICU. The patient-level risk factors for these family symptoms are not well understood but may help to target future interventions.

422. Simulation training improves diagnostic performance on a real patient with similar clinical findings.

作者: Kristin Fraser.;Bruce Wright.;Louis Girard.;Janet Tworek.;Mike Paget.;Lisa Welikovich.;Kevin McLaughlin.
来源: Chest. 2011年139卷2期376-381页
Training on a cardiopulmonary simulator improves subsequent diagnostic performance on the same simulator. But data are lacking on transfer of learning. The objective of this study was to determine whether training on a cardiorespiratory simulator improves diagnostic performance on a real patient.

423. Ultrasound accurately reflects the jugular venous examination but underestimates central venous pressure.

作者: Gur Raj Deol.;Nicole Collett.;Andrew Ashby.;Gregory A Schmidt.
来源: Chest. 2011年139卷1期95-100页
Bedside ultrasound examination could be used to assess jugular venous pressure (JVP), and thus central venous pressure (CVP), more reliably than clinical examination.

424. Resistance arm training in patients with COPD: A Randomized Controlled Trial.

作者: Tania Janaudis-Ferreira.;Kylie Hill.;Roger S Goldstein.;Priscila Robles-Ribeiro.;Marla K Beauchamp.;Thomas E Dolmage.;Karin Wadell.;Dina Brooks.
来源: Chest. 2011年139卷1期151-8页
The study aimed to evaluate the effect of upper extremity resistance training for patients with COPD on dyspnea during activity of daily living (ADL), arm function, arm exercise capacity, muscle strength, and health-related quality of life (HRQL).

425. Prevalence and recognition of obstructive sleep apnea in Chinese patients with type 2 diabetes mellitus.

作者: David C L Lam.;Macy M S Lui.;Jamie C M Lam.;Liza H Y Ong.;Karen S L Lam.;Mary S M Ip.
来源: Chest. 2010年138卷5期1101-7页
Obstructive sleep apnea (OSA) is associated with disorders of glucose metabolism. Previous studies revealed a high prevalence of OSA among subjects with type 2 diabetes mellitus (DM). The aims of this study were to determine the prevalence of OSA and associated clinical factors in Chinese patients with DM.

426. Performance of medical residents in sterile techniques during central vein catheterization: randomized trial of efficacy of simulation-based training.

作者: Hassan Khouli.;Katherine Jahnes.;Janet Shapiro.;Keith Rose.;Joseph Mathew.;Amit Gohil.;Qifa Han.;Andre Sotelo.;James Jones.;Adnan Aqeel.;Edward Eden.;Ethan Fried.
来源: Chest. 2011年139卷1期80-7页
Catheter-related bloodstream infection (CRBSI) is a preventable cause of a potentially lethal ICU infection. The optimal method to teach health-care providers correct sterile techniques during central vein catheterization (CVC) remains unclear.

427. Cysteine: a potential biomarker for obstructive sleep apnea.

作者: Fatima Cintra.;Sergio Tufik.;Vânia D'Almeida.;Bruno F A Calegare.;Angelo de Paola.;Wercules Oliveira.;Camila Rizzi.;Suely Roizenblatt.;Dalva Poyares.
来源: Chest. 2011年139卷2期246-252页
Obstructive sleep apnea (OSA) is a risk factor for a number of cardiovascular conditions. Although homocysteine (Hcy) and cysteine (Cys) are regarded as cardiovascular risk factors, few studies have analyzed Hcy and Cys plasma concentrations in patients with OSA. The aim of this study was to evaluate the role of Hcy and Cys in OSA in comparison with subjects without OSA and to determine the possible influence of obesity on these variables.

428. Reported pneumonia in patients with COPD: findings from the INSPIRE study.

作者: Peter M A Calverley.;Robert A Stockley.;Terence A R Seemungal.;Gerry Hagan.;Lisa R Willits.;John H Riley.;Jadwiga A Wedzicha.; .
来源: Chest. 2011年139卷3期505-512页
Pneumonia is an important complication of COPD and is reported more often in patients receiving inhaled corticosteroids (ICSs). Little is known about the clinical course and factors predisposing to pneumonia in patients with COPD. We investigated patient characteristics and symptoms occurring before pneumonia reports in the Investigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) study.

429. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.

作者: Johannes M A Daniels.;Marianne Schoorl.;Dominic Snijders.;Dirk L Knol.;René Lutter.;Henk M Jansen.;Wim G Boersma.
来源: Chest. 2010年138卷5期1108-15页
Rational prescription of antibiotics in acute exacerbations of COPD (AECOPD) requires predictive markers. We aimed to analyze whether markers of systemic inflammation can predict response to antibiotics in AECOPD.

430. The differential effect of gastroesophageal reflux disease on mechanostimulation and chemostimulation of the laryngopharynx.

作者: Sin-Yong Phua.;Lorcan McGarvey.;Meng Ngu.;Alvin Ing.
来源: Chest. 2010年138卷5期1180-5页
Laryngo-hypopharyngeal sensitivity (LPS) as measured by thresholds to mechanostimulation and chemostimulation is important in the prevention of pulmonary aspiration. The presence of gastroesophageal reflux disease (GERD) increases thresholds to mechanostimulation. However, the effect of GERD on thresholds to chemostimulation remains unknown. The aim of this study was to compare laryngo-hypopharyngeal thresholds to chemostimulation in subjects with GERD with those of healthy subjects and to determine the relationship between thresholds to mechanostimulation and chemostimulation.

431. Objective airway monitoring improves asthma control in the cold and flu season: a cluster randomized trial.

作者: Susan L Janson.;Kelly Wong McGrath.;Jack K Covington.;Robert B Baron.;Stephen C Lazarus.
来源: Chest. 2010年138卷5期1148-55页
The goals of asthma care are reductions in risk and impairment, but achieving these goals requires collaborative work between patients and their clinicians. The purpose of this study was to improve inhaled corticosteroid (ICS) adherence and asthma control by cueing therapeutic communication between patients with asthma and their primary care clinicians.

432. Reproducibility of peak oxygen uptake and other cardiopulmonary exercise parameters: implications for clinical trials and clinical practice.

作者: Steven J Keteyian.;Clinton A Brawner.;Jonathan K Ehrman.;Russell Ivanhoe.;John P Boehmer.;William T Abraham.; .
来源: Chest. 2010年138卷4期950-5页
Clinical trialists involved in projects aimed at assessing the impact of a device or therapy on exercise capacity must select an end point that can detect a therapy-derived change and do so in a manner that is both sensitive to the change and valid. Using baseline data from the Prospective Evaluation of Elastic Restraint to Lessen the Effects of Heart Failure (PEERLESS-HF) trial, we describe the coefficient of variation (CV) for peak oxygen uptake (Vo2) and other parameters measured during a cardiopulmonary exercise (CPX) test.

433. Does a low-density gas mixture or oxygen supplementation improve exercise training in COPD?

作者: Debora Scorsone.;Stefano Bartolini.;Riccardo Saporiti.;Fulvio Braido.;Michele Baroffio.;Riccardo Pellegrino.;Vito Brusasco.;Emanuele Crimi.
来源: Chest. 2010年138卷5期1133-9页
Low-density gas mixtures and oxygen (O₂) supplementation are known to improve physical performance and ventilatory adaptation during incremental maximal exercise in COPD. We investigated whether their combined use during intense physical training is also effective in ameliorating exercise tolerance in patients affected by moderate to severe COPD.

434. An international randomized multicenter comparison of nasal potential difference techniques.

作者: George M Solomon.;Michael W Konstan.;Michael Wilschanski.;Joanne Billings.;Isabelle Sermet-Gaudelus.;Frank Accurso.;François Vermeulen.;Elina Levin.;Heather Hathorne.;Ginger Reeves.;Gina Sabbatini.;Aubrey Hill.;Nicole Mayer-Hamblett.;Melissa Ashlock.;John Paul Clancy.;Steven M Rowe.
来源: Chest. 2010年138卷4期919-28页
The transepithelial nasal potential difference (NPD) is used to assess cystic fibrosis transmembrane conductance regulator (CFTR) activity. Unreliability, excessive artifacts, and lack of standardization of current testing systems can compromise its use as a diagnostic test and outcome measure for clinical trials.

435. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.

作者: Hervé Decousus.;Victor F Tapson.;Jean-François Bergmann.;Beng H Chong.;James B Froehlich.;Ajay K Kakkar.;Geno J Merli.;Manuel Monreal.;Mashio Nakamura.;Ricardo Pavanello.;Mario Pini.;Franco Piovella.;Frederick A Spencer.;Alex C Spyropoulos.;Alexander G G Turpie.;Rainer B Zotz.;Gordon Fitzgerald.;Frederick A Anderson.; .
来源: Chest. 2011年139卷1期69-79页
Acutely ill, hospitalized medical patients are at risk of VTE. Despite guidelines for VTE prevention, prophylaxis use in these patients is still poor, possibly because of fear of bleeding risk. We used data from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) to assess in-hospital bleeding incidence and to identify risk factors at admission associated with in-hospital bleeding risk in acutely ill medical patients.

436. The association between BMI and plasma cytokine levels in patients with acute lung injury.

作者: Renee D Stapleton.;Anne E Dixon.;Polly E Parsons.;Lorraine B Ware.;Benjamin T Suratt.; .
来源: Chest. 2010年138卷3期568-77页
Obesity is associated with poor outcomes in many diseases, although recent data suggest that acute lung injury (ALI) is an exception. This is particularly interesting because obesity is marked by increased levels of proinflammatory mediators associated with increased morbidity and mortality in ALI. We hypothesized that cytokine response might be attenuated in patients who are obese and critically ill or that obesity might modify the relationship between plasma cytokines and clinical outcomes in ALI.

437. Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD.

作者: Peter A Williamson.;Philip M Short.;Karine L Clearie.;Sriram Vaidyanathan.;Thomas C Fardon.;Laura J Howaniec.;Brian J Lipworth.
来源: Chest. 2010年138卷3期595-604页
Lowest receptor occupancy for a drug occurs at trough prior to the next dose. Previous studies have focused on the effects of triple therapy at peak dose intervals using forced expiratory maneuvers. Impulse oscillometry (IOS) and body plethysmography (PLETH) are more sensitive than spirometry to assess inhaled therapies in COPD.

438. Bronchial challenges and respiratory symptoms in elite swimmers and winter sport athletes: Airway hyperresponsiveness in asthma: its measurement and clinical significance.

作者: Valérie Bougault.;Julie Turmel.;Louis-Philippe Boulet.
来源: Chest. 2010年138卷2 Suppl期31S-37S页
This study was aimed at the following: (1) the prevalence of airway hyperresponsiveness (AHR) and exercise-induced bronchoconstriction (EIB) in swimmers and winter sport athletes according to the previously recommended regulatory sport agencies criteria, (2) the relationship between respiratory symptoms and AHR/EIB, (3) the impact of the chosen cutoff value for AHR on its prevalence, and (4) the effect on the prevalence of the positive eucapnic voluntary hyperpnea (EVH) test of using the highest vs the lowest spirometric post-EVH values to calculate the magnitude of the airway response. We compared the prevalence of respiratory symptoms with responses to methacholine challenge and EVH in 45 swimmers, 45 winter sport athletes, and 30 controls. Two methacholine challenge cutoffs for AHR were analyzed: <or= 4 mg/mL (the sport agencies' criteria for AHR) and <or= 16 mg/mL. Sixty percent of swimmers, 29% of winter sport athletes, and 17% of controls had evidence of EIB or AHR (with the <or= 4 mg/mL criteria). Among athletes with a methacholine provocative concentration inducing a 20% decrease in the FEV(1) between 4 and 16 mg/mL, 43% of swimmers and 100% of winter sport athletes were symptomatic (P < .05). Prevalence of positive EVH tests were 39% in swimmers, 24% in winter sport athletes, and 13% in controls when the highest FEV(1) value measured at each time point post-EVH was used to identify maximal response for calculation of airway response, although these prevalences were higher if we used the lowest value. This study suggests that AHR/EIB is frequent in swimmers, whereas the frequently reported respiratory symptoms in winter sport athletes are often not related to AHR/EIB. Furthermore, the choice of methods for assessing methacholine challenge and EVH responses influences the prevalences of AHR and EIB.

439. Predictors of time to death after terminal withdrawal of mechanical ventilation in the ICU.

作者: Colin R Cooke.;David L Hotchkin.;Ruth A Engelberg.;Lewis Rubinson.;J Randall Curtis.
来源: Chest. 2010年138卷2期289-97页
Little information exists about the expected time to death after terminal withdrawal of mechanical ventilation. We sought to determine the independent predictors of time to death after withdrawal of mechanical ventilation.

440. Effects of aerobic training on psychosocial morbidity and symptoms in patients with asthma: a randomized clinical trial.

作者: Felipe A R Mendes.;Raquel C Gonçalves.;Maria P T Nunes.;Beatriz M Saraiva-Romanholo.;Alberto Cukier.;Rafael Stelmach.;Wilson Jacob-Filho.;Milton A Martins.;Celso R F Carvalho.
来源: Chest. 2010年138卷2期331-7页
Asthma symptoms reduce patients' daily activities, impair their health-related quality of life (HRQoL), and increase their reports of anxiety and depression, all of which seem to be related to a decrease in asthma control. Aerobic exercise training is known to improve aerobic fitness and reduce dyspnea in asthmatics; however, its effect in reducing psychologic distress and symptoms remains poorly understood. We evaluated the role of an aerobic training program in improving HRQoL (primary aim) and reducing psychologic distress and asthma symptoms (secondary aims) for patients with moderate or severe persistent asthma.
共有 1695 条符合本次的查询结果, 用时 5.5953445 秒